Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaji Kumar

Showing results (391-400 of 516) with videos related to

Pageof 52
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Pomalidomide (CC4047) plus low-dose dexamethasone as therapy for relapsed multiple myelomaMartha Q Lacy, Suzanne R Hayman, Morie A Gertz, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 29, 2008
Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathyMartha Q Lacy, Angela Dispenzieri, Suzanne R Hayman, et al.
Leukemia|February 24, 2021
Disease monitoring with quantitative serum IgA levels provides a more reliable response assessment in multiple myeloma patientsAlissa Visram, Iuliana Vaxman, Abdullah S Al Saleh, et al.
American Journal of Hematology|June 8, 2026
Determinants of Long-Term Benefit From High Dose Melphalan With Autologous Stem Cell Transplant in AL AmyloidosisMaximilian J Steinhardt, Ute Hegenbart, Tamer Hellou, et al.
Leukemia|October 14, 2018
Primary systemic amyloidosis in patients with Waldenström macroglobulinemiaSaurabh Zanwar, Jithma P Abeykoon, Stephen M Ansell, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2014
Impact of pretransplant therapy and depth of disease response before autologous transplantation for multiple myelomaRavi Vij, Shaji Kumar, Mei-Jie Zhang, et al.
American Journal of Hematology|March 7, 2026
Predicting Early Mortality in Newly Diagnosed AL Amyloidosis: Development and Validation of the PACE Score for Daratumumab-Treated PatientsGeorge S Mellgard, Abdul-Hamid Bazarbachi, Saurabh Zanwar, et al.
Blood Cancer Journal|December 18, 2019
Mate pair sequencing outperforms fluorescence in situ hybridization in the genomic characterization of multiple myelomaJames Smadbeck, Jess F Peterson, Kathryn E Pearce, et al.
Genetics in Medicine Open|December 13, 2024
Disparity in the detection of chromosome 15 centromere in patients of African ancestry with a plasma cell neoplasmAlaa Koleilat, Hongwei Tang, Neeraj Sharma, et al.
American Journal of Hematology|July 8, 2023
Natural history, predictors of development of extramedullary disease, and treatment outcomes for patients with extramedullary multiple myelomaSaurabh Zanwar, Matthew Ho, Yi Lin, et al.
Pageof 52

Showing results (391-400 of 516) with videos related to

Sort By:
Pageof 52
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Pomalidomide (CC4047) plus low-dose dexamethasone as therapy for relapsed multiple myelomaMartha Q Lacy, Suzanne R Hayman, Morie A Gertz, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 29, 2008
Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathyMartha Q Lacy, Angela Dispenzieri, Suzanne R Hayman, et al.
Leukemia|February 24, 2021
Disease monitoring with quantitative serum IgA levels provides a more reliable response assessment in multiple myeloma patientsAlissa Visram, Iuliana Vaxman, Abdullah S Al Saleh, et al.
American Journal of Hematology|June 8, 2026
Determinants of Long-Term Benefit From High Dose Melphalan With Autologous Stem Cell Transplant in AL AmyloidosisMaximilian J Steinhardt, Ute Hegenbart, Tamer Hellou, et al.
Leukemia|October 14, 2018
Primary systemic amyloidosis in patients with Waldenström macroglobulinemiaSaurabh Zanwar, Jithma P Abeykoon, Stephen M Ansell, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2014
Impact of pretransplant therapy and depth of disease response before autologous transplantation for multiple myelomaRavi Vij, Shaji Kumar, Mei-Jie Zhang, et al.
American Journal of Hematology|March 7, 2026
Predicting Early Mortality in Newly Diagnosed AL Amyloidosis: Development and Validation of the PACE Score for Daratumumab-Treated PatientsGeorge S Mellgard, Abdul-Hamid Bazarbachi, Saurabh Zanwar, et al.
Blood Cancer Journal|December 18, 2019
Mate pair sequencing outperforms fluorescence in situ hybridization in the genomic characterization of multiple myelomaJames Smadbeck, Jess F Peterson, Kathryn E Pearce, et al.
Genetics in Medicine Open|December 13, 2024
Disparity in the detection of chromosome 15 centromere in patients of African ancestry with a plasma cell neoplasmAlaa Koleilat, Hongwei Tang, Neeraj Sharma, et al.
American Journal of Hematology|July 8, 2023
Natural history, predictors of development of extramedullary disease, and treatment outcomes for patients with extramedullary multiple myelomaSaurabh Zanwar, Matthew Ho, Yi Lin, et al.
Pageof 52